Observational studyFrontiers in immunology2026

CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.

Giulia Salvatore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.